Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Yuxin Pharmaceutical is a comprehensive pharmaceutical enterprise located in Yucheng, Shandong Province, China, specializing in the production of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. The company is a significant manufacturer of metabolic disease treatments, particularly oral hypoglycemic agents like metformin and sulfonylureas used in the management of type 2 diabetes. With multiple GMP-certified production lines, Shandong Yuxin Pharmaceutical supplies a variety of therapeutic products including cardiovascular, anti-infective, and gastrointestinal medications. The firm serves both the Chinese domestic market and international clients through its chemical synthesis and formulation capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Yuxin Pharmaceutical.